A few minutes to save a life

Studium Genetics - Alma Mater Studiorum University of Bologna, after more than ten years of research, thousands of clinical validation cases, international scientific publications and a worldwide patent in USA, Europe, China and Brazil, has developed a revolutionary, totally non-invasive Technology capable of detecting with high precision patients at risk of developing oral squamous cell carcinoma (OSCC) and its precursor, high grade dysplasia.

As recognised by the scientific medical community, practitioners and published data at national and international level, the mortality rate and aesthetic-functional consequences of oral cancer are closely dependent on the time of diagnosis.

With the SG-Ocra Programme, previewed at Expodental 2025, dentists and oral pathology physicians become the fundamental centre of the professional model of prevention and follow-up capable of detecting oral cancer no longer at an advanced stage (III-IV), but at an early stage (I-II) with clear benefits for the patient.